Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of combining the disulfiram (DSF) and copper
gluconate (Cu) to liposomal doxorubicin to treat patients with sarcomas that recurred or did
not respond to initial treatment.